This report studies the global market size of Intravenous (IV) Solution in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous (IV) Solution in these regions.
This research report categorizes the global Intravenous (IV) Solution market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls.
Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.
In 2017, the global Intravenous (IV) Solution market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Intravenous (IV) Solution market based on company, product type, application and key regions.
The various contributors involved in the value chain of Intravenous (IV) Solution include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Intravenous (IV) Solution include
ICU Medical
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols
Market Size Split by Type
by Product Type
Total Parenteral Solution
Peripheral Parenteral Solution
by Nutritional Content
Amino Acid Solution
Carbohydrates
Vitamins & Minerals
Parenteral Lipid Emulsion
Others
Market Size Split by Application
Hospitals & Clinics
Ambulatory
Homecare
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Intravenous (IV) Solution market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Intravenous (IV) Solution market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intravenous (IV) Solution manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intravenous (IV) Solution with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Intravenous (IV) Solution submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Intravenous (IV) Solution are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous (IV) Solution market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Intravenous (IV) Solution Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Intravenous (IV) Solution Market Size Growth Rate by Type
1.4.2 Total Parenteral Solution
1.4.3 Peripheral Parenteral Solution
1.5 Market by Application
1.5.1 Global Intravenous (IV) Solution Market Size Growth Rate by Application
1.5.2 Hospitals & Clinics
1.5.3 Ambulatory
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Intravenous (IV) Solution Market Size
2.1.1 Global Intravenous (IV) Solution Revenue 2016-2025
2.1.2 Global Intravenous (IV) Solution Sales 2016-2025
2.2 Intravenous (IV) Solution Growth Rate by Regions
2.2.1 Global Intravenous (IV) Solution Sales by Regions
2.2.2 Global Intravenous (IV) Solution Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Intravenous (IV) Solution Sales by Manufacturers
3.1.1 Intravenous (IV) Solution Sales by Manufacturers
3.1.2 Intravenous (IV) Solution Sales Market Share by Manufacturers
3.1.3 Global Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI)
3.2 Intravenous (IV) Solution Revenue by Manufacturers
3.2.1 Intravenous (IV) Solution Revenue by Manufacturers (2016-2018)
3.2.2 Intravenous (IV) Solution Revenue Share by Manufacturers (2016-2018)
3.3 Intravenous (IV) Solution Price by Manufacturers
3.4 Intravenous (IV) Solution Manufacturing Base Distribution, Product Types
3.4.1 Intravenous (IV) Solution Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intravenous (IV) Solution Product Category
3.4.3 Date of International Manufacturers Enter into Intravenous (IV) Solution Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Intravenous (IV) Solution Sales by Type
4.2 Global Intravenous (IV) Solution Revenue by Type
4.3 Intravenous (IV) Solution Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Intravenous (IV) Solution Breakdown Data by Application
6 North America
6.1 North America Intravenous (IV) Solution by Countries
6.1.1 North America Intravenous (IV) Solution Sales by Countries
6.1.2 North America Intravenous (IV) Solution Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Intravenous (IV) Solution by Type
6.3 North America Intravenous (IV) Solution by Application
6.4 North America Intravenous (IV) Solution by Company
7 Europe
7.1 Europe Intravenous (IV) Solution by Countries
7.1.1 Europe Intravenous (IV) Solution Sales by Countries
7.1.2 Europe Intravenous (IV) Solution Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intravenous (IV) Solution by Type
7.3 Europe Intravenous (IV) Solution by Application
7.4 Europe Intravenous (IV) Solution by Company
8 Asia Pacific
8.1 Asia Pacific Intravenous (IV) Solution by Countries
8.1.1 Asia Pacific Intravenous (IV) Solution Sales by Countries
8.1.2 Asia Pacific Intravenous (IV) Solution Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Intravenous (IV) Solution by Type
8.3 Asia Pacific Intravenous (IV) Solution by Application
8.4 Asia Pacific Intravenous (IV) Solution by Company
9 Central & South America
9.1 Central & South America Intravenous (IV) Solution by Countries
9.1.1 Central & South America Intravenous (IV) Solution Sales by Countries
9.1.2 Central & South America Intravenous (IV) Solution Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Intravenous (IV) Solution by Type
9.3 Central & South America Intravenous (IV) Solution by Application
9.4 Central & South America Intravenous (IV) Solution by Company
10 Middle East and Africa
10.1 Middle East and Africa Intravenous (IV) Solution by Countries
10.1.1 Middle East and Africa Intravenous (IV) Solution Sales by Countries
10.1.2 Middle East and Africa Intravenous (IV) Solution Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Intravenous (IV) Solution by Type
10.3 Middle East and Africa Intravenous (IV) Solution by Application
10.4 Middle East and Africa Intravenous (IV) Solution by Company
11 Company Profiles
11.1 ICU Medical
11.1.1 ICU Medical Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Intravenous (IV) Solution
11.1.4 Intravenous (IV) Solution Product Description
11.1.5 Recent Development
11.2 B. Braun Melsungen
11.2.1 B. Braun Melsungen Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Intravenous (IV) Solution
11.2.4 Intravenous (IV) Solution Product Description
11.2.5 Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Intravenous (IV) Solution
11.3.4 Intravenous (IV) Solution Product Description
11.3.5 Recent Development
11.4 Baxter
11.4.1 Baxter Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Intravenous (IV) Solution
11.4.4 Intravenous (IV) Solution Product Description
11.4.5 Recent Development
11.5 Amanta Healthcare
11.5.1 Amanta Healthcare Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Intravenous (IV) Solution
11.5.4 Intravenous (IV) Solution Product Description
11.5.5 Recent Development
11.6 Terumo Medical Corporation
11.6.1 Terumo Medical Corporation Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Intravenous (IV) Solution
11.6.4 Intravenous (IV) Solution Product Description
11.6.5 Recent Development
11.7 Grifols
11.7.1 Grifols Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Intravenous (IV) Solution
11.7.4 Intravenous (IV) Solution Product Description
11.7.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Intravenous (IV) Solution Raw Material
13.1.2 Intravenous (IV) Solution Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Intravenous (IV) Solution
Figure Global Intravenous (IV) Solution Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Intravenous (IV) Solution Production Market Share by Types (Product Category) in 2017
Figure Total Parenteral Solution Product Picture
Table Major Manufacturers of Total Parenteral Solution
Figure Peripheral Parenteral Solution Product Picture
Table Major Manufacturers of Peripheral Parenteral Solution
Table Global Intravenous (IV) Solution Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospitals & Clinics
Figure Ambulatory
Figure Homecare
Figure Intravenous (IV) Solution Report Years Considered
Figure Global Intravenous (IV) Solution Market Size 2016-2025 (Million US$)
Figure Global Intravenous (IV) Solution Sales 2016-2025 (K Units)
Table Global Intravenous (IV) Solution Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Intravenous (IV) Solution Sales by Regions 2016-2025 (K Units)
Table Global Intravenous (IV) Solution Sales Market Share by Regions 2016-2025
Figure Global Intravenous (IV) Solution Sales Market Share by Regions 2016-2025
Figure 2017 Global Intravenous (IV) Solution Sales Market Share by Regions
Table Global Intravenous (IV) Solution Revenue by Regions 2016-2025 (Million US$)
Table Global Intravenous (IV) Solution Revenue Market Share by Regions 2016-2025
Figure Global Intravenous (IV) Solution Revenue Market Share by Regions 2016-2025
Figure 2017 Global Intravenous (IV) Solution Revenue Market Share by Regions
Table Global Intravenous (IV) Solution Sales by Manufacturers (2016-2018) (K Units)
Table Global Intravenous (IV) Solution Sales Share by Manufacturers (2016-2018)
Figure Global Intravenous (IV) Solution Sales Share by Manufacturers in 2017
Table Intravenous (IV) Solution Revenue by Manufacturers (2016-2018) (Million US$)
Table Intravenous (IV) Solution Revenue Share by Manufacturers (2016-2018)
Figure Intravenous (IV) Solution Value Share by Manufacturers in 2017
Table Global Intravenous (IV) Solution Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Intravenous (IV) Solution Price (2016-2018) (USD/Unit)
Table Intravenous (IV) Solution Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Intravenous (IV) Solution Product Category
Table Date of International Manufacturers Enter into Intravenous (IV) Solution Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Intravenous (IV) Solution Sales by Type (2016-2025) (K Units)
Table Global Intravenous (IV) Solution Sales Share by Type (2016-2025)
Figure Global Intravenous (IV) Solution Sales Market Share by Type (2016-2025)
Figure Global Intravenous (IV) Solution Sales Market Share by Type in 2017
Table Global Intravenous (IV) Solution Revenue by Type (2016-2025) (Million US$)
Table Global Intravenous (IV) Solution Revenue Share by Type (2016-2025)
Figure Global Intravenous (IV) Solution Revenue Market Share by Type (2016-2025)
Figure Global Intravenous (IV) Solution Revenue Market Share by Type in 2017
Table Intravenous (IV) Solution Price by Type 2013-2018 (USD/Unit)
Table Global Intravenous (IV) Solution Sales by Application (2016-2025) (K Units)
Table Global Intravenous (IV) Solution Sales Share by Application (2016-2025)
Figure Global Sales Intravenous (IV) Solution Market Share by Application (2016-2025)
Figure Global Sales Intravenous (IV) Solution Market Share by Application (2016-2025)
Figure North America Intravenous (IV) Solution Sales Growth Rate 2016-2025 (K Units)
Figure North America Intravenous (IV) Solution Revenue Growth Rate 2016-2025 (Million US$)
Table North America Intravenous (IV) Solution Sales by Countries (2016-2025) (K Units)
Table North America Intravenous (IV) Solution Sales Market Share by Countries (2016-2025)
Figure 2017 North America Intravenous (IV) Solution Sales Market Share by Countries
Table North America Intravenous (IV) Solution Revenue by Countries (2016-2025) (Million US$)
Table North America Intravenous (IV) Solution Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Intravenous (IV) Solution Revenue Market Share by Countries
Figure United States Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure United States Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Canada Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Table North America Intravenous (IV) Solution Sales by Type (2016-2025) (K Units)
Table North America Intravenous (IV) Solution Sales Market Share by Type (2016-2025)
Figure 2017 North America Intravenous (IV) Solution Market Share by Type
Table North America Intravenous (IV) Solution Sales by Application (2016-2025) (K Units)
Table North America Intravenous (IV) Solution Sales Market Share by Application (2016-2025)
Figure 2017 North America Intravenous (IV) Solution Market Share by Application
Table North America Intravenous (IV) Solution Sales by Company (2016-2018) (K Units)
Table North America Intravenous (IV) Solution Sales Market Share by Company (2016-2018)
Figure North America Intravenous (IV) Solution Sales Market Share by Company in 2017
Figure Europe Intravenous (IV) Solution Sales Growth Rate 2016-2025 (K Units)
Figure Europe Intravenous (IV) Solution Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Intravenous (IV) Solution Sales by Countries (2016-2025) (K Units)
Table Europe Intravenous (IV) Solution Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Intravenous (IV) Solution Sales Market Share by Countries
Table Europe Intravenous (IV) Solution Revenue by Countries (2016-2025) (Million US$)
Table Europe Intravenous (IV) Solution Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Intravenous (IV) Solution Revenue Market Share by Countries
Figure Germany Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Germany Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (K Units)
Figure France Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure France Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (K Units)
Figure UK Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure UK Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Italy Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Russia Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Intravenous (IV) Solution Sales by Type (2016-2025) (K Units)
Table Europe Intravenous (IV) Solution Sales Market Share by Type (2016-2025)
Figure 2017 Europe Intravenous (IV) Solution Market Share by Type
Table Europe Intravenous (IV) Solution Sales by Application (2016-2025) (K Units)
Table Europe Intravenous (IV) Solution Sales Market Share by Application (2016-2025)
Figure 2017 Europe Intravenous (IV) Solution Market Share by Application
Table Europe Intravenous (IV) Solution Sales by Company (2016-2018) (K Units)
Table Europe Intravenous (IV) Solution Sales Market Share by Company (2016-2018)
Figure Europe Intravenous (IV) Solution Sales Market Share by Company in 2017
Figure Asia Pacific Intravenous (IV) Solution Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Intravenous (IV) Solution Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Intravenous (IV) Solution Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Intravenous (IV) Solution Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Intravenous (IV) Solution Sales Market Share by Countries
Table Asia Pacific Intravenous (IV) Solution Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Intravenous (IV) Solution Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Intravenous (IV) Solution Revenue Market Share by Countries
Figure China Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure China Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Japan Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Korea Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure India Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure India Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Australia Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Intravenous (IV) Solution Sales by Type (2016-2025) (K Units)
Table Asia Pacific Intravenous (IV) Solution Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Intravenous (IV) Solution Market Share by Type
Table Asia Pacific Intravenous (IV) Solution Sales by Application (2016-2025) (K Units)
Table Asia Pacific Intravenous (IV) Solution Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Intravenous (IV) Solution Market Share by Application
Table Asia Pacific Intravenous (IV) Solution Sales by Company (2016-2018) (K Units)
Table Asia Pacific Intravenous (IV) Solution Sales Market Share by Company (2016-2018)
Figure Asia Pacific Intravenous (IV) Solution Sales Market Share by Company in 2017
Figure Central & South America Intravenous (IV) Solution Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Intravenous (IV) Solution Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Intravenous (IV) Solution Sales by Countries (2016-2025) (K Units)
Table Central & South America Intravenous (IV) Solution Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Intravenous (IV) Solution Sales Market Share by Countries
Table Central & South America Intravenous (IV) Solution Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Intravenous (IV) Solution Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Intravenous (IV) Solution Revenue Market Share by Countries
Figure Brazil Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Intravenous (IV) Solution Sales by Type (2016-2025) (K Units)
Table Central & South America Intravenous (IV) Solution Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Intravenous (IV) Solution Market Share by Type
Table Central & South America Intravenous (IV) Solution Sales by Application (2016-2025) (K Units)
Table Central & South America Intravenous (IV) Solution Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Intravenous (IV) Solution Market Share by Application
Table Central & South America Intravenous (IV) Solution Sales by Company (2016-2018) (K Units)
Table Central & South America Intravenous (IV) Solution Sales Market Share by Company (2016-2018)
Figure Central & South America Intravenous (IV) Solution Sales Market Share by Company in 2017
Figure Middle East and Africa Intravenous (IV) Solution Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Intravenous (IV) Solution Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Intravenous (IV) Solution Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Intravenous (IV) Solution Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Intravenous (IV) Solution Sales Market Share by Countries
Table Middle East and Africa Intravenous (IV) Solution Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Countries
Figure GCC Countries Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Intravenous (IV) Solution Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Intravenous (IV) Solution Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Intravenous (IV) Solution Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Intravenous (IV) Solution Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Intravenous (IV) Solution Market Share by Type
Table Middle East and Africa Intravenous (IV) Solution Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Intravenous (IV) Solution Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Intravenous (IV) Solution Market Share by Application
Table Middle East and Africa Intravenous (IV) Solution Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Intravenous (IV) Solution Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Intravenous (IV) Solution Sales Market Share by Company in 2017
Table ICU Medical Company Details
Table ICU Medical Intravenous (IV) Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table ICU Medical Recent Development
Table B. Braun Melsungen Company Details
Table B. Braun Melsungen Intravenous (IV) Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table B. Braun Melsungen Recent Development
Table Fresenius Kabi Company Details
Table Fresenius Kabi Intravenous (IV) Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Fresenius Kabi Recent Development
Table Baxter Company Details
Table Baxter Intravenous (IV) Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Baxter Recent Development
Table Amanta Healthcare Company Details
Table Amanta Healthcare Intravenous (IV) Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Amanta Healthcare Recent Development
Table Terumo Medical Corporation Company Details
Table Terumo Medical Corporation Intravenous (IV) Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Terumo Medical Corporation Recent Development
Table Grifols Company Details
Table Grifols Intravenous (IV) Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Grifols Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Intravenous (IV) Solution Value Chain
Table Typical Suppliers of Key Intravenous (IV) Solution Raw Material
Table Intravenous (IV) Solution Customers List
Table Intravenous (IV) Solution Sales Channels
Table Intravenous (IV) Solution Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
